Array BioPharma (ARRY) MEK Deal 'Favorable', BMO Capital Says
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 3.68 -0.07 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.75 | 52 Week High | $7.27 | |||
| Open | $3.74 | 52 Week Low | $2.39 | |||
| Day High | $3.76 | P/E | N/A | |||
| Day Low | $3.60 | EPS | $-0.61 | |||
| Volume | 5,563,642 | |||||
